Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 9c

August 6, 2019 4:52 PM

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.37), $0.09 better than the analyst estimate of ($0.46).Dr. Simon Pimstone, Xenon’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found